- The Difference a Distinguishable Name Makes for Biosimilars, Morning Consult, Peter J. Pitts, November 18, 2015
- Biosimilar Drugs Need Clarification, The Hill, Peter J. Pitts, March 25, 2015
Biosimilars
RECENT NEWS
The coronavirus could help pharma reset its reputation in Washington
The coronavirus outbreak could be the pharmaceutical industry’s ticket to saving its reputation in Washington.... Read more
The biggest challenge facing the FDA’s new Rare Disease Innovation Hub
Differing philosophies within and outside of government could doom the hub... Read more
Tort bar’s newest collateral damage: Preterm babies
Lawsuits allege links between intestinal disease, infant formula and human milk fortifiers... Read more